Interventional Pain Management·Published September 2026
Paid faster, paid better: A/R days down 52%, per-visit collections up 12%
A four-location interventional pain management group in Georgia was losing routine injection claims to modifier errors and high-dollar procedures to authorization gaps. MBS moved every fix ahead of claim submission and cut A/R days from 60+ to 29.
Make clinical documentation defensible on medical necessity.
Replace reactive A/R chasing with prioritized follow-up.
Starting position
The challenges
High denial volume on routine procedures — epidural steroid injections, nerve blocks, facet injections — driven by missing or incorrect modifiers (25, 50, 59) and frequency-limit issues.
Denials on high-dollar procedures such as radiofrequency ablation, SI joint fusion, neurostimulator implants, and kyphoplasty, driven by missing or non-compliant prior authorizations.
Front-desk and billing teams relying on generalized billing workflows rather than pain-management-specific criteria.
Clearinghouse scrubbing rules not configured to catch specialty-specific coding and medical-necessity errors before submission.
Reactive, unprioritized A/R follow-up, with over 35% of the outstanding balance aged past 90 days before the engagement.
Solutions
What MBS put in place
1
Authorization and documentation before submission
A dedicated pre-auth team cross-references payer guidelines 72+ hours before every procedure.
Clearinghouse rules block RFA and spinal cord stimulator claims until the chart documents failed conservative treatment.
Custom EMR templates prompt clinicians to capture conservative care, pain scores, and anatomical levels.
2
Prioritized A/R follow-up
The A/R team segments claims by age, payer, and dollar value, and works high-dollar claims at 14–21 days.
Automated tracking flags claims stuck in clearinghouse hold or payer edit status.
3
Front-desk collections
Pre-procedure eligibility checks let the front desk collect copays and deductibles on the day of service.
New service lines billed correctly from day one: CMAT, cognitive testing, nerve conduction studies, and DME.
Impact
What changed
A/R days fell 52%, from 60+ days to 29 days.
Fewer denials, faster resolution: tighter modifier use reduced denials on high-volume injection work, while prior-authorization and conservative-care documentation did the same for RFA, SI joint fusion, neurostimulator implants, and kyphoplasty.
Per-visit collections rose from $77 to $86 as collections tightened on existing procedures and new service lines were brought onto billing.
Full leadership visibility: claims are automatically prioritized by age, payer, and dollar value, giving real-time visibility into A/R aging and claim status.
Recovery
Annual revenue collections
2022 to 2025
2022 to 2025
Year
Revenue collected
2022
$0.95M
2023
$2.37M
2024
$4.15M
2025
$6.09M
Time to first results
Full deployment took 60 days, with the first measurable results inside the same window.
Why it worked
The operating model behind the result
Prevention, not recovery: every fix sat before claim submission, not after denial.
One rulebook: pre-auth, EMR templates, and scrubber rules enforced the same medical-necessity criteria.
Fast to stand up: full deployment in 60 days.
A/R worked by value and age instead of in received order.
Want the same review of your own A/R and denials?
We will look at your aging, denial reasons, and first-pass rate and tell you what is recoverable. A 30-minute call. No obligation, no long sales pitch.